Concentrations sanguines d’antibiotiques chez les patients brûlés. Étude rétrospective sur cinq ans

Richard, 1994, Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains, J Infect Dis, 170, 377, 10.1093/infdis/170.2.377 Dell’Aquila, 2004, Serum levels of vancomycin should be monitored in burn patients, Burns, 30, 386, 10.1016/j.burns.2003.11.007 Potel, 2006, Dosage des antibiotiques en réanimation : quand et comment demander et interpréter les tests ?, Reanimation, 15, 187, 10.1016/j.reaurg.2006.03.011 Garraffo, 2005, Signification clinique des corrélations pharmacocinétique/pharmacodynamie des antibiotiques chez les patients de réanimation, Reanimation, 14, 264, 10.1016/j.reaurg.2005.04.006 Moore, 1987, Clinical response to aminoglycoside therapy: importance of the peak concentration to minimal inhibitory concentration, J Infect Dis, 155, 93, 10.1093/infdis/155.1.93 Jaehde, 1995, Clinical pharmacokinetics in patients with burns, Clin Pharmacokinet, 29, 15, 10.2165/00003088-199529010-00003 Saivin, 2000, Les perturbations générales de la pharmacocinétique des médicaments chez le sujet brûlé, Brulures, 1, 145 Lesne-Hulin, 1995, Pharmacocinétique des antibiotiques chez les brûlés, Therapie, 50, 575 Weinbren, 1999, Pharmacokinetics of antibiotics in burn patients, J Antimicrob Chemother, 44, 319, 10.1093/jac/44.3.319 Boucher, 1992, Pharmacokinetics of systematically administered antibiotics in patients with thermal injury, Clin Infect Dis, 14, 458, 10.1093/clinids/14.2.458 Pea, 2005, Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability, Clin Pharmacokinet, 44, 1009, 10.2165/00003088-200544100-00002 Lovering, 2009, Pharmacokinetic evaluation of linezolid in patients with major thermal injuries, J Antimicrob Chemother, 63, 553, 10.1093/jac/dkn541 Carlet, 2006, Antibiotic therapy in serious infectious states, Med Mal Infect, 36, 299, 10.1016/j.medmal.2006.02.002 Syposs, 1986, Serum level of antibiotics in burn patients, Zentralbl Chir, 111, 1519 Mehrotra, 2004, Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness, Intensive Care Med, 30, 2145, 10.1007/s00134-004-2428-9 Frimodt–Moller, 2002, How predictive is PK/PD for antimicrobial agents?, Int J Antimicrob Agents, 19, 333, 10.1016/S0924-8579(02)00029-8 Martin, 1989, Studies on clavulanic acid. Part 1. Stability of clavulanic acid in solutions of amines containing hydroxy groups, J Chem Soc [Perkin 2], 223, 10.1039/P29890000223 Conil, 2007, Pharmacokinetics of ceftazidime and cefepime in burn patients: the importance of age and creatinine clearance, Int J Pharmacol Ther, 45, 529, 10.5414/CPP45529 Rio Y, Leroy F, Humbert G, Didion J. Comparative ceftazidime serum concentrations during continuous infusion in healthy subjects and severe burn patients. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1994 (Abstract A 13). Miyagawa, 1999, Continuous ceftazidime infusions in critically ill surgical patients, J Infect Dis Pharm, 4, 25, 10.1300/J100v04n01_05 Nicolau, 1999, Pharmacokinetics of continuous and intermittent ceftazidime in intensive care unit patients with nosocomial pneumonia, Infect Dis Clin Pract, 8, 45, 10.1097/00019048-199901000-00009 Lipman, 1999, Continuous infusion ceftazidime in intensive care. A randomised controlled trial, J Antimicrob Chemother, 43, 309, 10.1093/jac/43.2.309 Viaene, 2002, Comparative stability of antipseudomonal agents administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor operated syringes (intensive care units), Antimicrob Agents Chemother, 46, 2327, 10.1128/AAC.46.8.2327-2332.2002 Chevrolet, 2004, Syndrome de détresse respiratoire aiguë, EMC pneumologie, 1, 143, 10.1016/j.emcpn.2004.08.001 Leder, 1999, The clinical efficacy of continuous – infusion flucloxacillin in serious staphylococcal sepsis, J Antimicrob Chemother, 43, 113, 10.1093/jac/43.1.113 Moore, 1987, Clinical response to aminoglycoside therapy: the importance of the ratio peak concentration to minimal inhibitory concentration, J Infect Dis, 155, 93, 10.1093/infdis/155.1.93 Maller, 1988, A study of amikacin given once (versus twice) daily in serious infection, J Antimicrob Chemother, 22, 75, 10.1093/jac/22.1.75 Marik, 1991, A prospective randomized study comparing once (versus twice) daily amikacine dosing in critically ill adults and paediatric patients, J Antimicrob Chemother, 28, 753, 10.1093/jac/28.5.753 Société française d’anesthésie et de réanimation. Antibiothérapie probabiliste des états septiques graves. Ann Fr Anesth Reanim 2004;23:1020–6. Zaske, 1976, Increased dosage requirements of gentamicin in burn patients, J Trauma, 16, 824, 10.1097/00005373-197610000-00014 Arnould JF, Le Floch R. Aminosides : la pharmacocinétique, la pharmacodynamie et la vraie vie. Société française d’étude et de traitement des brûlures, XXV congrès, Lille, 2005 (Abstract 3). Zaske, 1978, The necessity of increased doses of amikacin in burn patients, Surgery, 84, 603 Conil, 2006, Increased amikacin dosage requirements in burn patients receiving a once – daily regimen, Int J Antimicrob Agents, 28, 226, 10.1016/j.ijantimicag.2006.04.015 Hoey, 1997, Wide variations in single, daily – dose aminoglycoside pharmacokinetics in patients with burn injuries, J Burn Care Rehabil, 18, 116, 10.1097/00004630-199703000-00005 Drusano, 2004, Relationship between fluoroquinolones area under curve: minimum inhibitory concentration ratio and the probability of eradication of the infection pathogen, in patients with nosocomial pneumonia, J Infect Dis, 189, 1590, 10.1086/383320 Garrelts, 1996, Ciprofloxacin pharmacokinetics in burn patients, Antimicrob Agents Chemother, 40, 1153, 10.1128/AAC.40.5.1153 Lesne–Hulin, 1999, Clinical pharmacokinetics of ciprofloxacin in patients with major burns, Eur J Clin Pharmacol, 55, 515, 10.1007/s002280050666 Wysocki, 2001, Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized trial, Antimicrob Agents Chemother, 45, 2460, 10.1128/AAC.45.9.2460-2467.2001 Conil, 1994, Continuous administration of vancomycin in patients with severe burns, Presse Med, 23, 1554